Trending Articles

  1. Vetter strengthens senior management team for growth Three new managing directors to support global sustainable development
  2. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated
  3. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
  4. Syncona launches early-stage drug development company, Slingshot Therapeutics The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around...
  5. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in...

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing Baccinex has significant knowledge in sterile fill-finish processes for both lyophilised and liquid vials

CDMO Adragos Pharma acquires aseptic fill-finish manufacturing expert, Baccinex

Read more
Research & Development Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions

Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics

Read more
Manufacturing Three new managing directors to support global sustainable development

Vetter strengthens senior management team for growth

Read more
Finance The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

Read more
Research & Development The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around...

Syncona launches early-stage drug development company, Slingshot Therapeutics

Read more
Manufacturing Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity

Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger

Read more
Manufacturing The company will expand its biologics manufacturing, as well as its speciality manufacturing and cell therapy production capacity, while also extending its pharmaceutical...

AstraZeneca invests $3.5bn into its US pharmaceutical research and manufacturing capabilities

Read more
Manufacturing The CDMO faction of Evotec will now function as DAPIN GmbH, which will continue to specialise in end-to-end chemical API development and manufacturing

Evotec strikes up a deal with Monacum Partners to sell its Halle API manufacturing facility

Read more
Finance The MAP Group has continued its international expansion with the acquisition of SKC Beratungsgesellschaft mbH, significantly increasing expertise and headcount and expanding...

MAP Group broadens its European market access platform by adding SKC to its portfolio of companies

Read more
Manufacturing The novel automated facility will allow Accord to produce therapeutics for oncological and autoimmune diseases for the UK and beyond

Accord Healthcare bolsters UK drug manufacturing capabilities with £50m Newcastle facility

Read more
Manufacturing Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases

Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m

Read more
Manufacturing The facility's expansion has tripled its ADC manufacturing capacity, bolstering Merck's CDMO offering for current and new clients

Merck bolsters its ADC CDMO offering with €71m Missouri manufacturing site expansion

Read more
Manufacturing US$80 million Lexington expansion to double sterile fill-finish capacity

Piramal Pharma Limited reports robust growth in CDMO and sustainability initiatives

Read more
Finance The acquisition will add to AbbVie's Alzheimer's drug pipeline, while also allowing it access to Aliada's proprietary blood-brain barrier-crossing technology

AbbVie to bolster its neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition

Read more
Drug Delivery ViaNautis' polyNaut nanovesicles can deliver genetic materials to specific tissues or cell types, allowing for more accurate therapeutic targeting

Eli Lilly to leverage ViaNautis Bio's nanovesicle technology for genetic medicine development

Read more
Manufacturing The expansion will double the size and capacity of its Marietta site, supporting the manufacture of sterile liquid vaccines and production for clinical trials

GSK bolsters its US drug manufacturing capabilities with $800m investment

Read more